Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Barts Health Pharmaceuticals is the specialized pharmaceutical manufacturing and clinical trials service division of the Barts Health NHS Trust, the largest NHS trust in the United Kingdom. Based at The Royal London Hospital in Whitechapel, the unit is a licensed manufacturer of 'specials' (unlicensed medicines) and Investigational Medicinal Products (IMPs) used in clinical research. It provides a comprehensive suite of services to academic and industry partners, including formulation development, blinding, packaging, and global distribution of trial medications. As a core component of the Barts Life Sciences initiative, the unit plays a pivotal role in translating medical research into clinical practice, supporting a wide range of therapeutic areas such as oncology, cardiology, and neurology. The facility operates under stringent Good Manufacturing Practice (GMP) standards to ensure the safety and efficacy of the bespoke medicines it produces.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Barts Health Pharmaceuticals.